4 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 4 of 4 clinical reviews.
Economic analysis of combination levothyroxine plus liothyronine therapy based on the 1999 Bunevicius trial: cost per QALY modeling, payer coverage barriers, list-price realities, and individual value calculations.
Detailed breakdown of the Bunevicius 1999 trial results comparing T4+T3 combination therapy to T4 monotherapy, including effect sizes, secondary endpoints, and response patterns across cognitive and mood domains.
A deep-dive into the 1999 Bunevicius NEJM trial comparing levothyroxine plus liothyronine (T4+T3) to levothyroxine alone for hypothyroidism, covering methodology, results, limitations, and clinical relevance today.
A deep-dive into the 1999 Bunevicius crossover trial of levothyroxine plus liothyronine combination therapy, examining its real clinical implications, guideline responses, and which patients may benefit today.